The full activation of TLR signaling requires contributions of other signal pathways. Calcium and its major downstream effector, calcium/calmodulin-dependent protein kinase II (CaMKII), are found to be important for the functions of immune cells. LPS has been shown to induce intracellular calcium release in macrophages, however, whether and how CaMKII is required for TLR signaling remain unknown.
Introduction
Upon recognition of pathogenic components, Toll-like receptors (TLRs) are activated, leading to a variety of signaling events that initiate innate immunity and activate immune cells to produce proinflammatory cytokines and type I interferon. 1, 2 Most of the members of TLR family with the exception of TLR3 trigger immune response via conserved myeloid differentiation factor 88 (MyD88)-dependent pathway, which involves MyD88, IL-1 receptor-associated kinase 1 (IRAK1), TNF receptor-associated factor 6 (TRAF6), and TGF-β-activated kinase 1 (TAK1) and downstream mitogen-activated protein kinases (MAPKs) and nuclear factor κB (NF-κB). 2, 3 Toll/IL-1 receptor-domain-containing adaptor protein inducing IFN-β (TRIF) has been found to induce the expression of type I interferon in response to TLR4 and TLR3 ligands, which associates with TANK-binding kinase 1 (TBK1) and activates downstream interferon regulatory factor 3 (IRF3). In addition, TRIF pathway also contributes to TLR3-and TLR4-activated proinflammatory cytokine production. /CaM-independent kinase activity. 9 In addition, the phosphorylated subunit shows a 1000-fold increase in the affinity for CaM due to a marked change in the off rate. This unique mechanism Technology (Beverly, MA). Antibodies specific to TAK1, CaMKIIα and phospho-CaMKIIα were from Santa Cruz (Santa Cruz, CA). Anti-Flag and anti-β-actin antibodies were from Sigma.
Cell Culture and Transfection
Mouse macrophage cell line RAW264.7 and human HEK293 cell line were obtained from ATCC (Manassas, VA) and cultured as described. 20 The cells were transfected with JetPEI (Illkirch, France). Thioglycolate-elicited mouse peritoneal macrophages were prepared and cultured as described previously, 20 and nucleofected with mouse macrophage nucleofect kit using Amaxa Nucleofector II biosystems (Amaxa GmbH). 
Plasmid Constructs

RNA Interfering
The sequences of small interfering RNA targeting CaMKIIα were The primers used for mouse β-actin and IFN-4α analysis were described as previously. 20 Data were normalized by the level of β-actin expression in each sample.
Assay of Luciferase Reporter Gene Expression
RAW264.7 cells or HEK293 cells were co-transfected with the mixture of indicated luciferase reporter plasmid, pRL-TK-Renilla-luciferase plasmid, and 
Immunoblot and Immunoprecipitation
The nuclear and cytoplasmic extracts were prepared with NE-PER nuclear and cytoplasmic extraction reagents (Pierce, Rockford, IL). Immunoblot and immunoprecipitation were performed as described previously.
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In some immunoprecipitation experiments, a unique horseradish peroxidase-conjugated secondary antibody, mouse TrueBlot ULTRA (eBioscience) was used, which can minimize the reactivity with the heavy and light chains of the immunoprecipitating antibody.
GST Pull-down Assay
GST-tagged CaMKII (a.a. 1-300) (Santa Cruz, CA) was incubated with RAW264.7 cell lysates at 4°C for 30min, further incubated with Glutathione Sepharose 4B (Pierce) for 2 hr in IP buffer containing NP40. After washing three times, the precipitates were subjected to Western blot analysis.
Expression of GST Fusion Proteins
Wild-type and mutant GST-IRF-3 380-427 were expressed in Escherichia coli, and purified by GST affinity chromatography (Pierce). 
In vitro Kinase Assay
Purified GST-IRF3 protein or recombinant GST-TAK1 protein (Abnova, Taiwan)
was incubated with recombinant active CaMKIIα in the above CaMKII kinase assay system at 30°C for 30 min. Samples were separated by SDS-PAGE followed by autoradiography. For determining the activation of TAK1 by CaMKIIα, 5μg myelin basic protein (MBP) (Upstate) was added into the above reaction mixture followed by incubation for another 20 min. Samples were analyzed by immunobloting with anti-phospho-MBP antibody.
Statistical Analysis
Statistical significance was determined by the Student's t test or AVONA for multiple comparisons of normal distributions, with a value of P less than .05 considered to be statistically significant. Survival curves were compared by using the log-rank test.
For personal use only. on October 24, 2017. by guest www.bloodjournal.org From We also investigated whether CaMKII knockdown could regulate TLR-triggered proinflammatory cytokine and type I interferon production in macrophages. As shown in Figure 2B and Figure S4B , endogenous CaMKIIα expression in RAW264. For IRF3 is the key transcription factor that is activated through TRIF-dependent pathway and mediates the production of type I interferon in TLR3 and TLR4 signaling.
Results
TLR ligands induce intracellular Ca
26 IRF3 resides in the cytoplasm in resting cells and, upon stimulation, becomes activated via serine/threonine phosphorylation (between residues 385 and 405) leading to its dimerization, nuclear translocation and association with the coactivators CBP-p300. 27 Because activation of IRF-3 has been correlated with 28 we first observed the effects of CaMKII inhibition or activation on the phosphorylation level of IRF3 (Ser396). Inhibition of CaMKII by KN62 decreased LPS-induced phosphorylation of IRF3 (Ser396), consistently, CaMKII290 overexpression increased its phosphorylation ( Figure 4C ). In addition, KN62 treatment inhibited LPS-induced nuclear translocation of IRF3 in RAW264.7 cells, while CaMKII290 overexpression promoted its nuclear translocation ( Figure   4D ). By detecting IRF3 luciferase report gene expression in RAW264.7 cells, we found LPS-induced IRF3 activation was significantly inhibited by KN62 treatment but enhanced by CaMKII290 overexpression in a dose-dependent manner ( Figure 4E ).
Silencing of CaMKIIα expression also impaired IRF3 activation in LPS-stimulated macrophages (data not shown). CaMKII also enhanced poly(I:C)-induced IRF3 activation ( Figure S5 ). So, CaMKII plays an indispensable role in the full activation of IRF3 in TLR3 and TLR4 signaling, thus leading to the significant increase of TRIF-activated IFN-β production by CaMKII.
CaMKII directly binds and phosphorylates TAK1 promoting activation of TAK1
TAK1 is essential to the optimal MAPK, NF-κB activation and production of proinflammatory cytokines in TLR signaling. 29 We wondered whether CaMKII could interact with and activate TAK1. Immunoprecipitation experiments showed that
CaMKIIα could interact with TAK1 in LPS-stimulated macrophages ( Figure 5A , B),
suggesting that endogenous CaMKIIα could interact with TAK1 upon TLR4 activation.
For
org From
To investigate which region of CaMKIIα can interact with TAK1, various truncated or deleted mutants of CaMKIIα were constructed according to its known structural and functional domains, 8, 30 and then cotransfected into HEK293 cells with HA-tagged TAK1. Co-immunoprecipitation revealed that the N-terminal part of the regulatory domain (a.a. 260-300) of CaMKIIα was necessary for the interaction of CaMKIIα and TAK1 ( Figure 5C ).
To further confirm whether the N-terminal of CaMKIIα can directly bind to TAK1, GST pull-down assay was performed by incubating GST-tagged CaMKIIα (a.a.
1-300) with lysates. Blotting with anti-TAK1 antibody displayed that TAK1 could be pulled down with GST-tagged CaMKIIα ( Figure 5D ).
Then we tested whether CaMKII could phosphorylate TAK1. As shown in Figure   5E , recombinant active CaMKIIα directly phosphorylated recombinant TAK1 protein in vitro. To determine whether TAK1 can be activated by CaMKIIα, MBP was introduced into the reaction mixture of recombinant active CaMKIIα and TAK1
protein as a substrate of TAK1. Blotting with anti-phospho-MBP antibody showed that phosphorylation of MBP by TAK1 was enhanced in the presence of CaMKIIα ( Figure 5F ). Taken together, these results suggest that CaMKIIα directly binds and phosphorylates TAK1, which leads to the increased activation of TAK1.
CaMKII directly binds and phosphorylates IRF3 promoting IRF3-activated
IFN-β expression
To elucidate the underlying mechanism by which CaMKII enhances TLR3 and To determine the domain of CaMKIIα responsible for CaMKIIα-IRF3 interaction, various flag-tagged truncated or deleted mutants of CaMKIIα as described in Figure 5C were cotransfected into HEK293cells with HA-tagged IRF3 for co-immunoprecipitation experiments. N-terminal part of the regulatory domain (a.a. 260-300) of CaMKIIα was found to be necessary for its interaction with IRF3 ( Figure 6C ). In addition, GST pull-down assay using GST-tagged CaMKIIα (a.a. Figure   6E ). 
1-300) revealed that the N-terminal of CaMKIIα could directly bind IRF3 (
Blockade of CaMKII activation attenuates endotoxin shock in lethal LPS-challenged mice
For personal use only. on October 24, 2017. by guest www.bloodjournal.org From
21
Endotoxin shock is a severe systemic inflammatory response characterized by a progressive release of inflammatory mediators predominantly from monocytes and macrophages mainly including IL-6, TNF-α. 33 IFN-α/β also plays important roles in endotoxin shock. 34, 35 Considering that blockade of CaMKII activation by KN62 could suppress LPS-induced production of proinflammatory cytokine and IFN-β in macrophages, we wondered whether KN62 could protect mice from endotoxin shock to lethal LPS challenge. As expected, KN62-pretreated mice produced significantly less IL-6, TNF-α and IFN-β in vivo than control mice ( Figure 7A-C) . Consistently, all control mice died within 5 days after LPS in vivo administration, however 37.5% of KN62-pretreated mice still survived ( Figure 7D ), suggesting that CaMKII blockade could protect mice from endotoxin shock to lethal LPS challenge. Many proteins have been shown to be the substrates of CaMKII, and such proteins can be divided into two types: one group with an RXXS/T motif and the other group with no definitive motif except a preference of negative-charged residue at +2 position. 12 We for the first time have identified TAK1 and IRF3 as new substrates of CaMKIIα. We determined S386 of IRF3 as the targeted phosphorylation site of CaMKIIα. The IRF3 sequence surrounding S386, GASSLEN, is consistent with the second type of motif, which confirms our results, while, the targeted site(s)
of CaMKIIα in TAK1 remains unclear. The sequence surrounding the known phosphorylation sites of TAK1, Thr184, Thr187 and Ser192, 37 are all not consistent with the recognition motif of CaMKII, which implies that other target(s) of phosphorylation by CaMKII may exist.
TBK1 can directly phosphorylate IRF3 and the group 2 residues (serines 396, 398, 402, and 405 and threonine 404) are the primary targets of the phosphorylation. 31 However, It has been reported that the phosphorylation of IRF3 by TBK1 was not sufficient to impart transcriptional activity to IRF-3, although it was sufficient for IRF-3 dimerization and nuclear translocation. 5 Full activation of IRF-3 required further phosphorylation by the PI3K pathway, presumably of other specific Ser/Thr residue(s). 5 Our data also support this model of two-step phosphorylation of IRF3:
after TLR3 or TLR4 ligation, TBK1 phosphorylates IRF3 on S396 and other group 2 residues, leading to IRF-3 dimerization and nuclear translocation; then CaMKIIα directly binds and further phosphorylates IRF3 on S386 other than group 2 residues, leading to the enhanced phosphorylation (S396), nuclear translocation, transcriptional Increased Ca 2+ responses may be involved in the breakdown of B cell tolerance and autoimmunity in SLE. 40, 41 In addition, the disturbance of Ca 2+ signaling is related with the generation of autoreactive T cells, which play important roles in the development of rheumatoid arthritis, multiple sclerosis and type I diabetes. 40, 42 CaMKII, as a major and important downstream effector of Ca
2+
, may be also involved in the pathophysiological processes of these autoimmune diseases. Considering that TLR activation by endogenous ligands has an important role in the development of autoimmune disease, 43 whether the enhanced TLR activation by CaMKII is another mechanism for the pathogenesis of autoimmune diseases needs further investigation.
So, the involvement of dysregulated Ca 2+ /CaMKII signaling in the pathogenesis of Data are shown as mean ± SD (n = 5) of one typical experiment from three independent experiments with similar results. *, P < .05; **, P < .01. 
